HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Robbins Farley

Robbins Farley increased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 20.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,927 shares of the company's stock after acquiring an additional 987 shares during the period. Robbins Farley's holdings in HCA Healthcare were worth $2,048,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $1,021,000. Kestra Private Wealth Services LLC boosted its holdings in shares of HCA Healthcare by 15.4% in the fourth quarter. Kestra Private Wealth Services LLC now owns 2,288 shares of the company's stock valued at $687,000 after purchasing an additional 305 shares during the period. Savant Capital LLC lifted its holdings in HCA Healthcare by 4.1% during the fourth quarter. Savant Capital LLC now owns 3,673 shares of the company's stock worth $1,102,000 after buying an additional 146 shares during the period. Gladstone Institutional Advisory LLC lifted its holdings in shares of HCA Healthcare by 43.4% during the 4th quarter. Gladstone Institutional Advisory LLC now owns 859 shares of the company's stock valued at $258,000 after purchasing an additional 260 shares during the last quarter. Finally, Avestar Capital LLC increased its position in shares of HCA Healthcare by 27.5% in the 4th quarter. Avestar Capital LLC now owns 1,149 shares of the company's stock valued at $345,000 after acquiring an additional 248 shares during the period. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded down $0.91 during trading on Friday, hitting $370.76. 872,296 shares of the stock were exchanged, compared to its average volume of 1,452,711. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market cap of $89.20 billion, a PE ratio of 16.88, a P/E/G ratio of 1.10 and a beta of 1.49. The company has a fifty day moving average price of $358.43 and a two-hundred day moving average price of $333.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $5.36 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.78%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Barclays set a $416.00 price target on HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird reissued a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Royal Bank of Canada decreased their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $392.47.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.